Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.

Area of Science:

• Hepatology
• Public Health
• Virology

Background:

• Hepatitis B virus (HBV) infection is a widespread global health concern with significant public health implications.
• Challenges in HBV management include diverse transmission routes, a large chronic carrier population, vaccine non-response, and limited access to care and awareness.
• Chronic HBV infection is a major risk factor for developing hepatocellular carcinoma (HCC).

Purpose of the Study:

• To review the current challenges in managing Hepatitis B virus infections.
• To explore potential solutions and novel treatment strategies for HBV.
• To discuss the causal risk factors and mechanisms of hepatocellular carcinoma (HCC) linked to HBV.

Main Methods:

• This review synthesizes existing literature on HBV epidemiology, management, and HCC pathogenesis.
• It analyzes data concerning vaccination efficacy, treatment outcomes, and risk factors for HCC.
• The review focuses on identifying gaps and proposing future directions in HBV research and clinical practice.

Main Results:

• Despite vaccination, HBV remains a significant health issue globally, necessitating improved preventive and therapeutic strategies.
• Novel treatments, including combination therapy and gene silencing, show promise for managing HBV infection.
• Understanding the direct and indirect mechanisms by which HBV promotes HCC is crucial for prevention and treatment.

Conclusions:

• Scaling up universal HBV vaccination programs, particularly in developing regions, is essential to reduce new infections.
• Advancements in novel therapies are critical for the effective management of chronic HBV infection.
• Addressing HBV-related HCC requires a comprehensive approach encompassing prevention, early detection, and targeted therapies.